» Articles » PMID: 36703788

Diagnostic Value of Plasma RNF180 Gene Methylation for Gastric Cancer: A Systematic Review and Meta-analysis

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Jan 27
PMID 36703788
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: A systematic evaluation of the diagnostic value of Ring finger protein 180 (RNF180) gene methylation as a novel tumor marker for gastric cancer (GC) is required to improve the early diagnosis of gastric cancer patients.

Methods: Computer searches of PubMed, Web of Science, Embase, The Cochrane Library, CNKI, CBM, WanFang Data, National Research Register, Cclinical Controlled Trials, Opengrey and VIP databases were conducted from the database's inception to September 1, 2022. Two researchers independently screened the literature, extracted information, and assessed the risk of bias in studies that were included. The meta-analysis was carried out using RevMan 5.3 and Stata 16.0 software.

Results: A total of 9 studies with a total of 1531 subjects were included. A random-effects meta-analysis revealed that the combined sensitivity (SEN), specificity (SPE), positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) of plasma RNF180 gene methylation for the diagnosis of GC were: 0.54 [95% CI (0.45, 0.62)], 0.80 [95% CI (0.72, 0.87)], 2.73 [95% CI (2.09, 3.57)], 0.58 [95% CI (0.51, 0.65)], 4.74 [95% CI (3.59, 6.62)], respectively.

Conclusion: The detection of RNF180 gene methylation in plasma has a high diagnostic value for GC and is expected to be a potential biomarker for the diagnosis of gastric cancer, according to current evidence.

Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=370903, identifier CRD42022370903.

Citing Articles

Evaluation of a three-gene methylation model for correlating lymph node metastasis in postoperative early gastric cancer adjacent samples.

Chen S, Long S, Liu Y, Wang S, Hu Q, Fu L Front Oncol. 2024; 14:1432869.

PMID: 39484038 PMC: 11524798. DOI: 10.3389/fonc.2024.1432869.


Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy.

Cui Z, Zou F, Wang R, Wang L, Cheng F, Wang L World J Surg Oncol. 2023; 21(1):309.

PMID: 37759234 PMC: 10523704. DOI: 10.1186/s12957-023-03187-3.

References
1.
Cao C, Chang L, Wu Q . Circulating methylated Septin 9 and ring finger protein 180 for noninvasive diagnosis of early gastric cancer. Transl Cancer Res. 2022; 9(11):7012-7021. PMC: 8799148. DOI: 10.21037/tcr-20-1330. View

2.
Liu H, Yang P, Li X, Jia Y . Ring finger protein 180 is associated with biological behavior and prognosis in patients with non-small cell lung cancer. Oncol Lett. 2020; 20(4):35. PMC: 7412726. DOI: 10.3892/ol.2020.11898. View

3.
Necula L, Matei L, Dragu D, Neagu A, Mambet C, Nedeianu S . Recent advances in gastric cancer early diagnosis. World J Gastroenterol. 2019; 25(17):2029-2044. PMC: 6506585. DOI: 10.3748/wjg.v25.i17.2029. View

4.
Sun J, Zheng M, Li Y, Zhang S . Structure and function of Septin 9 and its role in human malignant tumors. World J Gastrointest Oncol. 2020; 12(6):619-631. PMC: 7340996. DOI: 10.4251/wjgo.v12.i6.619. View

5.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View